MTOR and chronic myelogenous leukemia, BCR-ABL1 positive: While Szyniarowski et al. (2011) did not find any effect on mTORC1 activity in breast cancer cell lines by analyzing the phosphorylation status its p70S6K [23], another study using chronic myeloid leukemia demonstrated suppressed autophagy by activating mTOR [22].